Across TCGA pan-cancer cohorts, LINC02656 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02656 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02656 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02656 expression acts as an unfavorable survival marker, although some lineages such as SKCM and BLCA show a favorable association.
COAD, SKCM, and KIRP are the cancer types where LINC02656 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.